Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 8Phase NA 4Phase 1 4Phase 4 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hemangioma 1Esophageal Stenosis 1Esophageal Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Steroids × Clear all
NCT05768282 2023-03-16

Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia

E-DA Hospital

Phase 4 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Esophageal Stenosis

NCT01908972 2018-12-19

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Seoul National University Hospital

Phase 4 Completed
34 enrolled 18 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡